Clinical Trials:

Because our goal is to develop a cure for brain cancer, we are actively conducting a number of clinical research projects at the Vanderbilt Brain Tumor Center.  Brain cancer is often very difficult to treat and traditional approaches are often not effective.  With that in mind, we are constantly searching for innovative ways to treat brain cancer and are committed to bringing promising ideas born in the research laboratory into clinical trials.  Vanderbilt-Ingram Cancer Center

Our Research

	Moneeb Ehtesham, M.D.
	Dr. Moneeb Ehtesham is Assistant Professor in the department of Neurological Surgery and Director of the Neurosurgical Oncology Research Laboratories.  Dr. Ehtesham's research focuses on the development of effective cell-based strategies to treat malignant brain tumors.  High grade gliomas, the most common primary brain tumors, are characterized by their highly infiltrative nature and often recur despite aggressive resection of the primary tumor mass with adjunct radio- and chemotherapy.  Dr. Ehtesham's work focuses on developing the use of progenitors and immune cells as tools to track down and specifically target infiltrative glioma cells in the brain.  The goal of his laboratory is develop these experimental approaches into translationally relevant treatment paradigms.  Dr. Ehtesham also has an interest in elucidating chemokine signaling mechanisms that govern the migratory capacity of glioma cells as well as neural progenitors in the brain, and how these signals regulate neural precusor cell differentiation in the specific setting of intracranial pathology.
	Link to CV

Innovative Technologies:

Vanderbilt University Medical Center is one of the nation’s premier medical institutions.  One of the strengths of the Vanderbilt Brain Tumor Center that sets it aside from most other centers for brain tumor research is access to innovative technologies.  You may view a list of some of the Innovative Technologies at Vanderbilt Medical Center here:  View Innovative Technologies!